Skip to main content
BrainCited

Bacopa monnieri के लिए Age-Related Cognitive Decline

B

A network meta-analysis found Bacopa outperformed Ginkgo on memory outcomes in elderly participants. Research suggests enhanced delayed word recall and improved Stroop Task performance with consistent supplementation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dbacopa\u002Dmonnieri\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

निष्कर्ष

A network meta-analysis found Bacopa outperformed Ginkgo on memory outcomes in elderly participants. Research suggests enhanced delayed word recall and improved Stroop Task performance with consistent supplementation.

Key Study Findings

Randomized Controlled Trial 6 weeks Double-blind
Effects of Bacopa monnieri herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in …
Dose: 120 mL twice daily for 45 days बनाम: placebo Outcome: telomerase activity and telomere length प्रभाव: None None

जनसंख्या: elderly participants with MoCA score >=24

Randomized Controlled Trial n=76 12 weeks Double-blind
Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients …
Dose: 300 mg/day standardized Bacopa monnieri extract बनाम: placebo Outcome: change in composite z score of memory at … प्रभाव: None None

जनसंख्या: patients with amnestic mild cognitive impairment, mean age 62.2 years, 88.3% men

Other
Differential Alterations in the Expression of AMPA Receptor and Its Trafficking Proteins in the Hippocampus …
Dose: 200 mg/kg body weight बनाम: Rotenone-PD mice without BME Outcome: Recognition memory and AMPA receptor expression प्रभाव: None None

जनसंख्या: Rotenone-induced Parkinson's disease mouse model

Systematic Review
Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer's Treatment: Systematic Review.
Dose: None बनाम: None Outcome: Cholinesterase inhibition and cognitive improvement प्रभाव: None None

जनसंख्या: In vivo animal models of AD

Other
A systems biology approach reveals dual neurotherapeutic mechanisms of Dioscorea bulbifera in Alzheimer's disease via …
Dose: None बनाम: Donepezil, Estradiol Outcome: Neurotherapeutic activity via ESR1 and ACHE प्रभाव: None None

जनसंख्या: In silico AD modeling (systems biology)

Systematic Review n=1861
The effect of plant active substances on cognitive function in healthy older adults: a systematic …
Dose: None बनाम: Placebo or no intervention Outcome: Cognitive function (learning, memory, executive) प्रभाव: Raisin SUCRA 95.1%; tart cherry 89.5% for memory None

जनसंख्या: Healthy older adults

Key Statistics

15

अध्ययन

1200

प्रतिभागी

Positive

B

ग्रेड

Referenced Papers

The Senior care … 2021 2 उद्धरण
Pharmacological research 2018 67 उद्धरण
Evidence-based complementary and … 2015 82 उद्धरण
Neurochemical research 2012 85 उद्धरण
Alternative medicine review … 1999 112 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
300-600 mg/day standardized to 50% bacosides
memorysupport:
300 mg/day for minimum 8-12 weeks

अधिकतम सीमा: Not established; well-tolerated up to 600 mg/day in trials

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
120 mL twice daily for 45 days 6 weeks Neutral --
300 mg/day standardized Bacopa monnieri extract 12 weeks Neutral 76
200 mg/kg body weight -- Positive --
None -- Positive --
None -- Positive --
None -- Positive 1861
None -- Mixed --
None 12 weeks Positive --

सेवन का सर्वोत्तम समय: With meals; effects require 8-12 weeks of consistent use

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Gastrointestinal discomfort (nausea, cramping, diarrhea)
  • Dry mouth
  • Fatigue in some individuals
  • Mild sedation at higher doses

ज्ञात अंतःक्रियाएँ

  • Thyroid medications (may increase thyroid hormone levels)
  • Anticholinergic drugs (opposes cholinergic enhancement)
  • Sedative medications (additive CNS depression)
  • Calcium channel blockers (may enhance blood pressure lowering)

सहनीय अधिकतम सेवन: Not established; well-tolerated up to 600 mg/day in trials

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Bacopa monnieri help with Age-Related Cognitive Decline?
Based on 15 studies with 1,200 participants, there is moderate evidence from clinical studies that Bacopa monnieri may support Age-Related Cognitive Decline management. Our evidence grade is B (Good Evidence).
How much Bacopa monnieri should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 300-600 mg/day standardized to 50% bacosides. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bacopa monnieri?
Reported side effects may include Gastrointestinal discomfort (nausea, cramping, diarrhea), Dry mouth, Fatigue in some individuals, Mild sedation at higher doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bacopa monnieri and Age-Related Cognitive Decline?
We rate the evidence as Grade B (Good Evidence). This rating is based on 15 peer-reviewed studies with 1,200 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Age-Related Cognitive Decline

Bacopa monnieri अन्य स्वास्थ्य स्थितियों के लिए

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।